High-sensitivity method for the determination of LSD and 2-oxo-3-hydroxy-LSD in oral fluid by liquid chromatography‒tandem mass spectrometry
- PMID: 36454414
- DOI: 10.1007/s11419-022-00622-0
High-sensitivity method for the determination of LSD and 2-oxo-3-hydroxy-LSD in oral fluid by liquid chromatography‒tandem mass spectrometry
Abstract
Purpose: We have developed and validated a high-sensitivity method to quantify lysergic acid diethylamide (LSD) and 2-oxo-3-hydroxy-LSD (OH-LSD) in oral fluid samples using liquid-liquid extraction and liquid chromatography-tandem mass spectrometry (LC‒MS/MS). The method was applied to the quantification of both substances in 42 authentic oral fluid samples.
Methods: A liquid-liquid extraction was performed using 500 µL each of samples (oral fluid samples collected using Quantisal™ device) and dichloromethane/isopropanol mixture (1:1, v/v). Enzymatic hydrolysis was evaluated to cleave glucuronide metabolites.
Results: The limit of quantification was 0.01 ng/mL for both LSD and OH-LSD. The linearity was assessed between 0.01 and 5 ng/mL. Imprecision and bias were not higher than 10.2% for both analytes. Extraction recovery was higher than 69%. The analytes were stable in the autosampler at 10 °C for 24 h, and up to 30 days at 4 and -20 °C. The method was applied to the analysis of 42 oral fluid samples. LSD was detected in all samples (concentrations between 0.02 and 175 ng/mL), and OH-LSD was detected in 20 samples (concentrations between 0.01 and 1.53 ng/mL).
Conclusions: A high-sensitive method was fully validated and applied to authentic samples. To our knowledge, this is the first work to report concentrations of LSD and OH-LSD in authentic oral fluid samples.
Keywords: 2-Oxo-3-hydroxy-LSD (OH-LSD); Authentic samples; LC‒MS/MS; Lysergic acid diethylamide (LSD); Oral fluid.
© 2022. The Author(s), under exclusive licence to Japanese Association of Forensic Toxicology.
Similar articles
-
Development and validation of an LC-MS/MS method to quantify lysergic acid diethylamide (LSD), iso-LSD, 2-oxo-3-hydroxy-LSD, and nor-LSD and identify novel metabolites in plasma samples in a controlled clinical trial.J Clin Lab Anal. 2018 Feb;32(2):e22265. doi: 10.1002/jcla.22265. Epub 2017 May 26. J Clin Lab Anal. 2018. PMID: 28548305 Free PMC article. Clinical Trial.
-
Simultaneous determination of LSD and 2-oxo-3-hydroxy LSD in hair and urine by LC-MS/MS and its application to forensic cases.J Pharm Biomed Anal. 2015 Nov 10;115:138-43. doi: 10.1016/j.jpba.2015.07.001. Epub 2015 Jul 7. J Pharm Biomed Anal. 2015. PMID: 26188861
-
Development and validation of an ultra-fast and sensitive microflow liquid chromatography-tandem mass spectrometry (MFLC-MS/MS) method for quantification of LSD and its metabolites in plasma and application to a controlled LSD administration study in humans.Drug Test Anal. 2017 May;9(5):788-797. doi: 10.1002/dta.2042. Epub 2016 Aug 10. Drug Test Anal. 2017. PMID: 27422082
-
Recent advances in chromatographic and mass spectrometric methods for determination of LSD and its metabolites in physiological specimens.J Chromatogr B Biomed Sci Appl. 1999 Oct 15;733(1-2):145-59. doi: 10.1016/s0378-4347(99)00189-9. J Chromatogr B Biomed Sci Appl. 1999. PMID: 10572980 Review.
-
Metabolism of lysergic acid diethylamide (LSD): an update.Drug Metab Rev. 2019 Aug;51(3):378-387. doi: 10.1080/03602532.2019.1638931. Epub 2019 Jul 16. Drug Metab Rev. 2019. PMID: 31266388 Review.
Cited by
-
Stability-Guided Formulation of a Light-Sensitive D-LSD Capsule for Clinical Investigation.Pharmaceutics. 2025 Jun 11;17(6):767. doi: 10.3390/pharmaceutics17060767. Pharmaceutics. 2025. PMID: 40574079 Free PMC article.
References
-
- Marta RFLO (2019) Metabolism of lysergic acid diethylamide (LSD): an update. Drug Metab Rev 51:378–387. https://doi.org/10.1080/03602532.2019.1638931 - DOI
-
- Verstraete AG (2004) Detection times of drugs of abuse in blood, urine, and oral fluid. Ther Drug Monit 26:200–205. https://doi.org/10.1097/00007691-200404000-00020 - DOI - PubMed
-
- Poch GK, Klette KL, Hallare DA, Manglicmot MG, Czarny RJ, McWhorter LK, Anderson CJ (1999) Detection of metabolites of lysergic acid diethylamide (LSD) in human urine specimens: 2-oxo-3-hydroxy-LSD, a prevalent metabolite of LSD. J Chromatogr B 724:23–33. https://doi.org/10.1016/S0378-4347(98)00574-X - DOI
-
- Poch GK, Klette KL, Anderson C (2000) The quantitation of 2-oxo-3-hydroxy lysergic acid diethylamide (O-H-LSD) in human urine specimens, a metabolite of LSD: comparative analysis using liquid chromatography-selected ion monitoring mass spectrometry and liquid chromatography-ion trap mass spectrometry. J Anal Toxicol 24:170–179. https://doi.org/10.1093/jat/24.3.170 (open access article) - DOI - PubMed
-
- Klette KL, Anderson CJ, Poch GK, Nimrod AC, ElSohly MA (2000) Metabolism of lysergic acid diethylamide (LSD) to 2-oxo-3-hydroxy LSD (O-H-LSD) in human liver microsomes and cryopreserved human hepatocytes. J Anal Toxicol 24:550–556. https://doi.org/10.1093/jat/24.7.550 (open access article) - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources